Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc

KROS

Date	Type	Insider	Position	Ø-Price	Volume
7/15/2026	Buy	Bienaime, Jean Jacques	Director	$10.6	$10,610
6/15/2026	Buy	Bienaime, Jean Jacques	Director	$10.2	$10,190
6/11/2026	Sell	Newton, Charles W.	Director	$10.0	$5,522
6/4/2026	Sell	Seth, Alpna	Director	$10.7	$28,140
6/4/2026	Sell	Farzan, Nima	Director	$10.7	$28,166
6/4/2026	Sell	Knowles, Julius	Director	$10.7	$28,166
5/15/2026	Buy	Bienaime, Jean Jacques	Director	$10.6	$10,580
4/15/2026	Buy	Bienaime, Jean Jacques	Director	$11.7	$11,700
3/9/2026	Buy	Bienaime, Jean Jacques	Director	$11.2	$22,420
2/19/2026	Sell	Seehra, Jasbir	CHIEF EXECUTIVE OFFICER	$16.2	$113,433
2/18/2026	Sell	Regnante, Keith	CHIEF FINANCIAL OFFICER	$16.4	$77,483
2/18/2026	Sell	Lerner, Lorena Raquel	Chief Science Officer	$16.4	$63,324
2/18/2026	Sell	Cho, Esther	SVP, General Counsel	$16.4	$77,581
10/15/2025	Sell	Adar1 Capital Management, LLC	Ten Percent Owner	$17.8	$95,659,437
10/15/2025	Sell	Pontifax Management 4 G.p. (2015) Ltd.	Ten Percent Owner	$17.8	$84,975,126
4/9/2025	Buy	Adar1 Capital Management, LLC	Ten Percent Owner	$9.9	$9,464,512
8/13/2024	Sell	Orbimed Advisors LLC	Director	$44.0	$11,002,500
8/13/2024	Sell	Gordon, Carl L.	Director	$44.0	$11,002,500